A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors. | NeoGenomics Laboratories

Publication date

Thu, 04/15/2021 - 12:00

Category

Year

Subtitle

AACR 2021

File

AACR_2021_Poster_2238_control_3643_final.pdf (535.81 KB)

Division